Oral antimicrobial agents in patients with short bowel syndrome: worth a try!

BACKGROUND: The use of oral antimicrobial agents in patients with short bowel syndrome (SBS) is challenging due to the changes in gastrointestinal anatomy that may result in diminished absorption and altered drug bioavailability. Prospective studies evaluating bioavailability of antimicrobial agents...

Descripción completa

Detalles Bibliográficos
Autores principales: Korzilius, Julia W, Gompelman, Michelle, Wezendonk, Guus T J, Jager, Nynke G L, Rovers, Chantal P, Brüggemann, Roger J M, Wanten, Geert J A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393866/
https://www.ncbi.nlm.nih.gov/pubmed/37390353
http://dx.doi.org/10.1093/jac/dkad198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393866/
https://www.ncbi.nlm.nih.gov/pubmed/37390353
http://dx.doi.org/10.1093/jac/dkad198

Ejemplares similares